Poniard Pharmaceuticals, Inc. (Nasdaq: PARD) today announced that Ronald Martell has been appointed to the position of CEO, succeeding Jerry ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE